Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy
Background Enhanced glucose metabolism has been reported in many cancers. Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme involved in the pentose phosphate pathway, which maintains NADPH levels and protects cells from oxidative damage. We recently found that low G6PD expression co...
Saved in:
| Main Authors: | Akimichi Morita, Hiroshi Kato, Motoki Nakamura, Maki Yoshimitsu, Tetsuya Magara, Katsuhiro Okuda, Keisuke Yokota, Shinji Kano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/7/e008441.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methemoglobinemia and Glucose-6-phosphate Dehydrogenase Deficiency in a Neonate
by: Saurabh Aggarwal, et al.
Published: (2025-01-01) -
Novel inhibitors of mitochondrial sn-glycerol 3-phosphate dehydrogenase.
by: Adam L Orr, et al.
Published: (2014-01-01) -
Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01) -
Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria.
by: Benedikt Ley, et al.
Published: (2022-05-01) -
Mitochondrial glycerol 3‐phosphate dehydrogenase promotes skeletal muscle regeneration
by: Xiufei Liu, et al.
Published: (2018-11-01)